Drugs /
hypofractionated proton radiation therapy
Back to Drugs List
Overview
Hypofractionated proton radiation therapy has been investigated in 3 clinical trials, of which 3 are open and 0 are closed. Of the trials investigating hypofractionated proton radiation therapy, 1 is phase 3 (1 open) and 2 are no phase specified (2 open).
Prostate adenocarcinoma and prostate carcinoma are the most common diseases being investigated in hypofractionated proton radiation therapy clinical trials [2].
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.
